ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,293Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 208

$1.61M Total Retail Price of All Prescriptions

Rank: 3 out of 208

1,045 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,045 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

4% of this provider’s 1,045 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 10,378 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 51%.

Prescription Price

$131 was the average price of a prescription from this provider, compared to $143 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SYNTHROID 947 799 1 2
ATORVASTATIN CALCIUM 524 443 2 15
LEVOTHYROXINE SODIUM 301 212 3 1
PEN NEEDLE 263 220 4 3
LEVEMIR FLEXPEN 248 213 5 19
FUROSEMIDE 218 204 6 24
GLIMEPIRIDE 205 177 7 10
METOPROLOL TARTRATE 201 196 8 33
INSULIN SYRINGE 195 123 9 9
METFORMIN HCL ER 187 164 10 13
JANUVIA 182 168 11 12
SIMVASTATIN 177 144 12 6
AMLODIPINE BESYLATE 177 151 12 20
METFORMIN HCL 173 114 14 4
WARFARIN SODIUM 164 133 15 58
LANTUS SOLOSTAR 162 109 16 5
LOVAZA 153 131 17 39
NOVOLOG MIX 70-30 FLEXPEN 149 116 18 21
ATENOLOL 148 140 19 49
VICTOZA 3-PAK 145 108 20 44
OMEPRAZOLE 144 126 21 36
TRADJENTA 138 124 22 78
LISINOPRIL 131 101 23 14
BENICAR HCT 130 112 24 102
GABAPENTIN 124 111 25 38
PANTOPRAZOLE SODIUM 123 113 26 60
LANTUS 123 96 26 7
HYDROCODONE-ACETAMINOPHEN 115 106 S3 28 45
ZETIA 110 110 29 30
HUMALOG 108 44 30 8
LOSARTAN POTASSIUM 107 89 31 34
METHIMAZOLE 106 94 32 17
LIPITOR 104 93 33 67
NOVOLOG FLEXPEN 98 73 34 11
KOMBIGLYZE XR 95 87 35 116
CLOPIDOGREL 95 91 35 66
HYDROCHLOROTHIAZIDE 94 69 37 29
BENICAR 90 75 38 161
NOVOFINE 90 85 38 92
GLIPIZIDE 88 85 40 23
DIOVAN 87 86 41 42
CITALOPRAM HBR 86 74 42 69
AZITHROMYCIN 84 73 43 81
DONEPEZIL HCL 80 80 44 62
NEXIUM 76 73 45 65
PLAVIX 71 66 46 82
PAROXETINE HCL 71 57 46 112
DIOVAN HCT 70 67 48 98
ISOSORBIDE MONONITRATE ER 70 66 48 103
DIGOXIN 64 61 50 95
JANUMET 64 59 50 28
PRAVASTATIN SODIUM 64 59 50 27
TRAMADOL HCL 64 49 50 100
HUMALOG MIX 75-25 63 41 54 25
BYETTA 62 53 55 41
POTASSIUM CHLORIDE 59 59 56 54
ONGLYZA 59 59 56 73
TRICOR 57 48 58 90
CELEBREX 56 56 59 125
LYRICA 55 48 60 189
TAMSULOSIN HCL 55 46 60 87
NOVOLOG 54 41 62 18
NAMENDA 52 52 63 85
GLIPIZIDE XL 51 51 64 37
ALLOPURINOL 50 46 65 84
ANDROGEL 50 29 S3 65 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.